Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program Read more
reVision Therapeutics Announces License with Cornell to Develop Treatment for Stargardt Disease Read more
Applied BioMath Announces Collaboration with Flame Biosciences for Systems Pharmacology Modeling in Lung Cancer Read more
Seneca Therapeutics Licenses Tumor Endothelial Marker 8 (TEM8) to Enable Better Patient Selection for SVV-001 Therapy Read more
Vor Biopharma and Metagenomi to Collaborate on Engineered Hematopoietic Stem-Cell Therapies Read more
Rocket Pharmaceuticals Receives FDA Fast Track Designation for RP-L401 Gene Therapy for Infantile Malignant Osteopetrosis Read more